SAN FRANCISCO--(BUSINESS WIRE)--Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application ...

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

The MarketWatch News Department was not involved in the creation of this content. THE WOODLANDS, Texas, Dec. 2, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development ...

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use. Single-use bioreactors come in all shapes and sizes that fit the ...

Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...

Laupheim, Germany, March 23, 2015 / B3C newswire / -- Rentschler Biotechnologie GmbH, a leading contract manufacturing and development organization (CDMO) for biopharmaceuticals, announced today that ...

SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...

CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing ...

Lakewwod, Colorado, US, September 19, 2022 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announces the launch of its Quantum Flex Cell Expansion System, a ...

A platform approach to bioprocessing uses the same set of protocols and systems found during early phase development. Scientists then transfer the protocols, by either scaling-up or scaling-out, ...

Global interest in cell and gene therapies is on the rise, and continued growth is expected for the coming years. To discuss the challenges and solutions associated with manufacturing viral vectors at ...